Trial Profile
Prevention of VZV [varicella-zoster virus] reactivation using long-term low-dose valacyclovir after allogeneic hematopoietic stem cell transplantation.
Status:
Completed
Phase of Trial:
Clinical Phase Unknown
Latest Information Update: 17 Jan 2012
Price :
$35
*
At a glance
- Drugs Valaciclovir (Primary)
- Indications Chickenpox; Herpes zoster
- Focus Therapeutic Use
- 06 Mar 2007 New trial record.